Abstract
Introduction
Hospital-acquired pneumonia (HAP) is the most common infection in the intensive care unit (ICU) [1] . In the ICU, HAP is associated with a mortality rate of 20% and with increased duration of mechanical ventilation and ICU and hospital length-of-stay [2, 3] . The criteria to diagnose pneumonia are shown in Table 1 (Fig. 1 ).
Method
Sixteen French-speaking experts produce guidelines in three specific areas related to HAP: prevention, diagnosis and treatment as well as the specificities pertaining to different identified patient populations (COPD, neutropenia, post-operative and paediatric). The schedule of the group was defined upstream ( Table 2) (Fig. 2) .
The questions were formulated according to the PICO (Patient, Intervention, Comparison, Outcome) format. The formulation of the guidelines was conducted according to the GRADE methodology (Grade of Recommendation Assessment, Development and Evaluation) [4, 5] . In the absence of supporting literature, a question could be addressed by a recommendation under the form of an expert opinion ("the experts suggest that…") ( Fig. 3) . These guidelines with their arguments were published in the journal Anaesthesia Critical Care and Pain Medicine [6] (Fig. 4) .
Open Access
First area, PREVENTION Which HAP prevention approaches decrease morbidity and mortality in ICU patients?
R1.1 We recommend using a standardised multimodal HAP prevention approach in order to decrease ICU patient morbidity (Grade 1+). R1.1 Paediatrics We suggest using a standardised multimodal approach aiming at preventing HAP in order to decrease paediatric ICU patient morbidity (Grade 2+).
R1.2
In units where multidrug-resistant bacteria prevalence is low (< 20%), we suggest applying routine selective digestive decontamination using a topical antiseptic administered enterally and a maximal 5-day course of systemic prophylactic antibiotic to decrease mortality (Grade 2+). R1.3 Within a standardised multimodal HAP prevention approach, we suggest combining some of the following methods to decrease ICU patient morbidity:
• Promote the use of non-invasive ventilation to avoid tracheal intubation (mainly in post-operative digestive surgery patients and in patients with COPD), • Favour orotracheal over nasotracheal intubation when required 
4-Avoid using the following methods:
Systematic early tracheotomy (apart from specific indications) -Antiulcer prophylaxis (apart from specific indications) -Post-pyloric enteral feeding (apart from specific indications) -Probiotics -Systematic early changing of humidifier filters (apart from a recommendation from the manufacturer) -Closed endo-tracheal suction systems -The use of intubation tubes lined/coated or incorporating silver or antiseptics, or with an "optimised" cuff shape -Oro-pharyngeal decontamination using povidone-iodine -Prophylactic nebulised antibiotics -Daily skin decontamination using antiseptics PreparaƟon for selecƟve digesƟve decontaminaƟon (provided for information purposes only) *Risk factors for non-fermenƟng Gram-negaƟve bacilli: anƟbioƟc therapy in the previous 90 days, prior hospital stay of more than 5 days, renal replacement therapy requirement during pneumonia, sepƟc shock, acute respiratory distress syndrome. **Methicillin-resistant Staphylococcus aureus (MRSA) risk factors: high local prevalence of MRSA, recent colonisaƟon by MRSA, chronic skin lesions, chronic renal replacement therapy.
Protocol 4

Fig. 4 Treatment options (expert opinion)
• Limit dose and duration of sedatives and analgesics (promote their use guided by sedation/pain/ agitation scales, and/or daily interruptions), • Initiate early enteral feeding (within the first 48 h of ICU admission), • Regularly verify endotracheal tube cuff pressure, • Perform sub-glottic suction (every 6 to 8 h) using an appropriate endotracheal tube (Grade 2+).
R1.4 Within a standardised multimodal HAP prevention approach, we suggest not using the following methods to decrease ICU patient morbidity:
• Systematic early (< day 7) tracheotomy (except for specific indications), • Anti-ulcer prophylaxis (except for specific indications), R1.5 In weaning of COPD patients from ventilation, we suggest using non-invasive ventilation to reduce length of invasive mechanical ventilation, incidence of HAP, morbidity and mortality (Grade 2+). 
Second area, DIAGNOSIS
